Medical Health Cluster

COVID

Molnupiravir Reduces COVID-19–Associated Mortality and Risk for Long COVID

When started within 5 days after symptom onset, molnupiravir lowered risk for post-acute death and long-COVID sequelae regardless of vaccination status or reinfection. Long COVID is a multifaceted condition with persistent post-acute and chronic sequelae. Previous reports indicated that full vaccination and antiviral treatment with nirmatrelvir/ritonavir (Paxlovid) were both associated […]

Read More

México en la quincena: termina emergencia sanitaria por COVID-19

México termina emergencia sanitaria por COVID-19 A más de tres años de la declaración de emergencia sanitaria por causa de fuerza mayor en el territorio mexicano, el gobierno anunció el fin de la emergencia sanitaria, ya que el país cumple con las características establecidas por la Organización Mundial de la […]

Read More

Corticosteroid Dose in Patients Hospitalized with COVID-19

In patients requiring conventional oxygen support, giving a higher dose of dexamethasone raised risk for death compared with standard-dose corticosteroids. In patients hospitalized with COVID-19 who require oxygen support, dexamethasone (6 mg daily for 10 days) reduces mortality and is standard of care. Now, in a randomized open-label trial, the […]

Read More

CDC simplifies COVID-19 vaccine recommendations, allows older adults and immunocompromised adults to get second dose of the updated vaccine

Following FDA regulatory action, CDC has taken steps to simplify COVID-19 vaccine recommendations and allow more flexibility for people at higher risk who want the option of added protection from additional COVID-19 vaccine doses. CDC’s Advisory Committee on Immunization Practices (ACIP) met today to discuss these COVID-19 vaccine recommendation changes, […]

Read More